{"id":"NCT00520676","sponsor":"Eli Lilly and Company","briefTitle":"Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer","officialTitle":"A Randomized Phase 3 Study Comparing Pemetrexed-Carboplatin With Docetaxel-Carboplatin as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10","primaryCompletion":"2010-07","completion":"2010-07","firstPosted":"2007-08-24","resultsPosted":"2011-07-18","lastUpdate":"2011-08-10"},"enrollment":260,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"pemetrexed","otherNames":["LY231514","Alimta"]},{"type":"DRUG","name":"docetaxel","otherNames":[]},{"type":"DRUG","name":"carboplatin","otherNames":[]}],"arms":[{"label":"pemetrexed plus carboplatin","type":"EXPERIMENTAL"},{"label":"docetaxel plus carboplatin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the combination of pemetrexed and carboplatin with the combination of docetaxel and carboplatin in terms of survival without Grade 3 or 4 toxicity in previously untreated patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).","primaryOutcome":{"measure":"Survival Without Grade 3 or 4 Toxicity","timeFrame":"Baseline to until 218 events (defined as death or Grade 3 or 4 toxicity) have been observed (up to 33.3 months).","effectByArm":[{"arm":"Pemetrexed Plus Carboplatin","deltaMin":3.2,"sd":null},{"arm":"Docetaxel Plus Carboplatin","deltaMin":0.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":20,"countries":["Australia","Brazil","China","Mexico","South Korea","Taiwan"]},"refs":{"pmids":["37922432","24277116"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":28,"n":106},"commonTop":["Neutropenia","Leukopenia","Nausea","Decreased appetite","Alopecia"]}}